Retrospective cohort study reveals enhanced immune function and reduced tumor markers in cancer patients, indicating therapeutic promise.
Deep hyperthermia is associated with significantly improves hematological parameters and reduces specific tumor markers in cancer patients, with a favorable safety profile. It suggests potential benefits in enhancing immune function, correcting anemia, and reducing bleeding risk, and can serve as an effective adjuvant therapy for malignant tumors.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: